Navigation Links
ResMed Takes New Action to Enforce Patents
Date:7/22/2013

SAN DIEGO, July 22, 2013 /PRNewswire/ -- ResMed (NYSE: RMD), an innovator and pioneer in developing products for the treatment of sleep-disordered breathing and respiratory conditions, has filed a new legal action in the International Trade Commission (ITC) and an amended complaint in U.S. federal court to stop the infringement of ResMed patents.

(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

ResMed filed the action against Chinese medical device manufacturer BMC Medical Co., Ltd. (BMC) and its U.S. sales subsidiary, 3B Products, LLC, (3B) asserting patent infringement by:

  • The RESmart CPAP and RESmart Auto CPAP devices
  • The Willow nasal pillows patient interface and the iVolve nasal mask.
  • ResMed is asking the ITC to stop the importation and sales of these products in the United States. ResMed has also amended a pending action in the U.S. federal court to assert additional patents that BMC and 3B are infringing.  ResMed is asking the court to stop the infringement and to award damages against BMC and 3B. 

    "ResMed built its market leadership by investing in superior technology for sleep-disordered breathing therapy," said ResMed global general counsel and chief administrative officer David Pendarvis.  "The proprietary technology in our masks and flow generators makes them comfortable and user-friendly, and our data management and reporting tools create a faster, smoother path to patient engagement. We will continue to defend our proprietary technology by enforcing our patents against those who unfairly copy our products."

    About ResMed:
    ResMed is a global leader in the development, manufacturing and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit www.resmed.com.Contacts:For News MediaFor the Investor CommunityGretchen GriswoldConstance BienfaitDirector, Global Corporate CommunicationsDirector, Investor RelationsO: 858-836-6789O: 858-836-5971news@resmed.comconstance.bienfait@resmed.com 


    '/>"/>
    SOURCE ResMed Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. ResMed Succeeds in Patent Fight Against APEX
    2. The Zacks Analyst Blog Highlights: Walgreens, Express Scripts Holding, Haemonetics, ResMed and Eli Lilly
    3. FDA Approvals, Diversified Product Pipeline, Produce Sales Growth, and Positive Study Outcomes - Research Report on Boston Scientific, Zimmer, St. Jude, ResMed, and GenMark
    4. ResMed Takes Action to Enforce Patents Against BMC and 3B
    5. ResMed Launches SleepSeeker Online Tool to Increase Patient Engagement in Therapy for Sleep-Disordered Breathing
    6. The University of Sydney and ResMed partner to accelerate research in sleep-disordered breathing and biomedical engineering
    7. ResMed Inc. Announces Record Financial Results For The Quarter Ended And Nine Months Ended March 31, 2013
    8. ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment
    9. ResMed Announces Conference Call And Webcast To Discuss Third Quarter 2013 Results
    10. ResMed Takes Action to Enforce Patents
    11. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/24/2017)... Research and Markets has announced the addition of the ... 2022" report to their offering. ... The global wound care market was worth $24,482.9 million in ... during 2016-2022 Among the various wound care products type, the ... market in 2015. Among the various applications, surgical wound segment held the ...
    (Date:3/24/2017)... Research and Markets has announced the addition of the "Dental ... ... markets for Dental Implants in US$ Million. The report provides separate comprehensive ... , Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period 2015 through ...
    (Date:3/24/2017)... 24, 2017 ShangPharma, a leading ... cost-effective drug development and discovery services, technology, ... industry, announced today the intent for a ... be consolidating the Contract Research Organizations (CRO) ... ChemPartner. These entities include ChemPartner Shanghai, ChemPartner ...
    Breaking Medicine Technology:
    (Date:3/24/2017)... ... 2017 , ... Judy Buchanan, co-owner of Serenity Natural Health ... says, “I am passionate about sharing Reiki as a holistic, complementary therapy with ... time.” , A Certified Medical Reiki™ Master trained by Raven Keys Medical Reiki™ ...
    (Date:3/24/2017)... ... ... “End Time GPS”: a dauntless and enlightened study of the second-coming of Christ, ... of published author, Wesley Gerboth, a World War II veteran, with a highly-regarded reputation ... age ninety-one, he shares the Wisdom God bestowed upon him in this publication. ...
    (Date:3/24/2017)... ... March 24, 2017 , ... ... stories about real people of God in congregations across the United States. ... Presbyterian minister ordained in 1964 who has served congregations in seven states throughout ...
    (Date:3/23/2017)... Greensboro, NC & Seattle, WA (PRWEB) , ... March 23, 2017 ... ... international public health emergency and now estimates that there could be four million Zika-related ... fastest growing epidemics to date with numbers of US cases reported per year skyrocketing ...
    (Date:3/23/2017)... ... March 23, 2017 , ... The physicians of KSF ... the greater Houston Area. The new location is located at 2255 E. Mossy Oaks ... Springwoods Village. This newest location will provide patients living in the north Houston area ...
    Breaking Medicine News(10 mins):